South East Asia Nutraceutical Excipients Market (2025 - 2030)

Market Size & Trends

The Southeast Asia nutraceutical excipients market size was valued at USD 968.2 million in 2024 and is projected to grow at a CAGR of 7.0% from 2025 to 2030. The Southeast Asian region offers substantial growth prospects, which are attributed to the rising healthcare expenditures and continuous economic expansion of the countries in the region. The rising awareness about health and well-being, coupled with the increasing disposable income, is helping the demand for tailored nutraceutical solutions.

Countries with low-cost production, such as India and China, have aided the growth of pharmaceutical companies in this region, such as nutraceutical startups and novel nutraceutical CDMOs. In October 2024, Nutrabay, a sports nutrition company, reported that the market demand for reasonably priced, superior sports nutrition products has caused its private label to see an 80% increase since 2023. Direct-to-consumer (D2C) businesses that provide nutraceuticals are drawing interest from investors as Indian consumers place a greater emphasis on preventative healthcare.

Nutraceutical excipients, which come from both pharmaceutical and nutritional sources, improve the bioavailability, stability, and absorption of active pharmaceutical ingredients (API) in drugs. Although they don’t have any therapeutic value by themselves, they make it possible to create functional foods and supplements that maximize the effectiveness and potency of pharmaceuticals. Growing consumer knowledge of the health advantages of nutritional foods, including food supplements, and busy lives have been cited as contributing factors to the emergence of functional foods.

The 2024 Child Poverty Report published by UNICEF revealed that the lack of a nutritious and diverse diet deprived 59 million (45%) young children from optimal growth and development opportunities in East Asia and the Pacific. Consequently, the region’s rising population also poses a significant driver for market growth. Key market players are diversifying their product offerings to aid nutritional proliferation throughout the region. For instance, in April 2024, Roquette Frères exhibited two additional products to its LYCAGEL pea starch excipient range at Vitafoods Europe. This offering aimed to develop alternative softgel-based dietary supplements for vegan and vegetarian consumers.

Market Concentration & Characteristics

The market growth stage is high, and the pace of growth is accelerating. The nutraceutical excipients industry is characterized by a high degree of innovation owing to rapid advancements, increasing research and development, technological advancements in formulation and drug delivery, and an increasing focus on bioavailability and stability.

Subsequently, the trend for tailored nutritional solutions also drives market growth. The nutraceutical excipient industry is also characterized by a moderate level of merger and acquisition (M&A) activity. This is due to several factors, such as the aim to access new technologies and talent, the need to consolidate in a rapidly growing market, and the increasing demand for dietary supplements.

Regulatory scrutiny of the nutraceutical excipients market in Southeast Asia has been on the rise in recent years. This increased focus is due to the crucial role excipients play in the formulation, safety, stability, and efficacy of nutraceutical products consumed by a growing health-conscious population. As a result, governments around Southeast Asia are developing regulations to govern the quality and safety of these excipients. For instance, in Singapore, the Health Sciences Authority (HSA) has complete authority over the excipients used in nutraceutical formulations. These regulations have a significant impact on the adoption of specific excipients to meet the required standard.

The nutraceutical industry traditionally relies on synthetic or semi-synthetic excipients. However, growing consumer preference for sustainable products is driving a shift towards natural alternatives for these functional ingredients, acting as primary product substitutes to this industry.

Product Insights

The film coating segment led the market with a revenue share of 12.4% in 2024, driven by the increasing consumer demand for nutraceuticals for preventive healthcare and wellness, consequently leading to the increased demand for film coating. Film coating has numerous advantages for patients, customers, and producers, ranging from hiding unpleasant tastes and odors to shielding over-the-counter medications, prescription medications, and supplements from environmental stressors. In February 2025, Roquette Frères launched ReadiLYCOAT, a new coating platform designed to meet the growing demand in prescription pharmaceutical, nutraceutical, and OTC markets. With this platform, the company aimed to enhance its excipient portfolio with reliable, high-quality options to meet customers’ diverse needs.

The modified release segment is expected to grow at the fastest CAGR 8.0% from 2025 to 2030, driven by increasing demand for generic drugs and patient-centric formulations. Controlled drug release, formulation stability, and efficacy make them essential in the nutraceutical and pharmaceutical industry’s product offerings. BASF, a major chemical company, has several options (such as Kollidon SR and Kollicoat SR 30 D) that help formulate the exact modified or sustained release profile needed to avoid unwanted dose dumping.

Country Insights

The Singapore nutraceutical excipients market held the largest revenue share of 15.0% in the Southeast Asia market in 2024. According to the International Trade Administration, Singapore’s robust economy, fast-paced lifestyles, and health awareness have fueled the growth of the health supplement industry. The Singapore Food Agency (SFA) regulates the food industry, including nutraceuticals and health supplements. In January 2024, the SFA proposed to make amendments to Regulation 18(1) of the Food Regulations to substitute the current variations of steviol glycosides with the four types of steviol glycosides produced by different methods to ensure compliance with the guidelines established by Codex Alimentarius Commission.

Malaysia Nutraceutical Excipients Market Trends

The nutraceutical excipients market in Malaysia is expected to grow lucratively over the forecast period. The Malaysian population is multicultural and has various culinary and cultural preferences. This diversity leads to demand for a range of nutraceutical products tailored to different customers. Their interest in dietary supplements and preventive healthcare fits well with the nutraceutical sector.

Cambodia Nutraceutical Excipients Market Trends

The Cambodia nutraceutical excipients market is expected to grow at the fastest CAGR of 8.7% over the forecast period. The SEA region is anticipated to have the world’s fastest economic growth, supporting middle-class customers in growing economies such as Cambodia with more disposable incomes who may actively look for health solutions or immune system boosters.

Key South East Asia Nutraceutical Excipients Company Insights

Some key companies in Southeast Asia nutraceutical excipients market include SPI Pharma; DuPont; Dow; Barentz; Cargill, Incorporated; BASF; and others. Organizations are focusing on the customer base to gain a competitive edge in the industry and introduce novel ways of manufacturing dietary supplements and nutraceutical excipients.

• SPI Pharma specializes in innovative excipients and drug delivery systems for the nutraceutical and pharmaceutical sectors in Southeast Asia. It offers solutions such as film coatings and modified-release technologies to enhance tablet stability, taste masking, and bioavailability.

• JRS PHARMA is a leading global provider of excipient solutions, supplying binders, fillers, and disintegrants for nutraceutical applications. In Southeast Asia, the company meets the demand for functional foods with high-quality excipients that optimize tablet flowability and uniformity.

Recent Developments

• In October 2024, Seppic launched a powder grade of SEPIBLISS, its nutraceutical active ingredient, dedicated to skin multiprotection due to customer demand for variety of galenic formulations.

• In July 2024, Barentz acquired the Anshul Life Sciences Group (“Anshul Life Sciences”), an Indian-origin distribution platform for life sciences, to widen the company’s network toward highly regulated personal care, pharmaceuticals, and food & nutraceuticals markets in the Asia Pacific region.

• In May 2024, Lubrizol showcased its LIPOFER microencapsulation technology and announced EU food-grade approval for Carbopol polymers at Vitafoods Europe, enhancing consumer-centric nutraceutical solutions in the European market.

Southeast Asia Nutraceutical Excipients Market